Product
Long-acting Octreotide
1 clinical trial
1 indication
Clinical trial
A Phase III Multi-center, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NETStatus: Active (not recruiting), Estimated PCD: 2023-07-20